Deep Brain Stimulators (DBS) Market Expected To Reach USD 1.59 billion By 2020

Deep brain stimulators (DBS) market is expected to register a significant growth rate over the forecast period owing to an upsurge in incidences of Parkinson’s and other neurological disorders such as Dystonia, OCD, essential tremor, Epilepsy and Alzheimer’s. Deep brain stimulation is based on the artificial stimulation provided by a pacemaker to the electrodes in the subthalamic region of the brain. It is instrumental in providing symptomatic relief to Parkinson’s patients on medications and with moderate disability. DBS provide QALY (quality adjusted life years) by improving motor symptoms and is helpful in pain management. For Market Research Report on “Deep Brain Stimulators (DBS) Market” Visit – [caption id="attachment_606" align="aligncenter" width="344"]Global deep brain stimulators market, by region, 2012 – 2020 (USD Million) Global deep brain stimulators market, by region, 2012 – 2020 (USD Million)[/caption] Increasing R&D pertaining to DBS is leading to the introduction of technologically advanced product such as electric current fractionated IPG (implantable pulse generator). This feature enables variable electric current proportions between multi polar lead. Another product design allows selective current steering via direction oriented electrode contacts, effective in delivering stimulation in specific direction and specific tissue, thereby avoiding adjacent tissue stimulation and thus side effects due to the same. Closed loop adaptive stimulation technologies are being developed which would be helpful in providing “on demand” stimulation. Brain computer interfaces helps in tracking momentary symptoms fluctuations especially in Parkinson’s. Furthermore, a computer based feedback signal allows stimulation only when necessary, which is helpful in improving therapeutic efficacy while limiting side effects and preserving battery life. Technological advancements and increasing applicability of DBS in various psychiatric disorder treatments is expected to serve this market with growth platform over next six years. DBS found the largest usage in North America thereby dominating the regional market with respect to revenue share in 2013. The dominance is due to presence of favorable reimbursement policies and sophisticated healthcare infrastructure. Europe follows North America to be the second largest market for DBS owing to increasing target disease prevalence. Increasing patient awareness levels, unmet needs coupled with rising disposable income levels in the emerging economies such as China and India is expected to provide lucrative growth platform to Asia Pacific territory over the forecast period. The market is competitive in nature with key participants focusing on providing technologically advanced products and increasing market penetration. Key players of DBS market are Boston Scientific, Medtronic Plc, Aleva Neurotherapeutics SA and St. Jude Medical Inc. Deep Brain Stimulators (DBS) Market Information Source: Grand View Research